Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
35
pubmed:dateCreated
1992-1-17
pubmed:abstractText
In the preceding paper (Paulweber, B., Onasch, M. A., Nagy, B. P., and Levy-Wilson, B. (1991) J. Biol. Chem. 266, 24149-24160) we demonstrated that the segment of the apolipoprotein B promoter extending from -260 to -85 is functionally different in hepatic (HepG2) and intestinal (CaCo-2) cells. These functional differences could be explained at least in part by differences in binding of three nuclear proteins to the region from -111 to -88. In this article we present further evidence suggesting that the mechanisms involved in transcriptional control of the apolipoprotein B gene in HepG2 and CaCo-2 cells are different, by demonstrating that an enhancer and a reducer can alter the activity of various apolipoprotein B promoter segments in widely differing ways in these two cell lines. Furthermore, we have localized a 329-base pair segment that is found within a negative regulatory region in the 5' distal portion of the gene. It displays a strong reducer effect upon promoter sequences that exhibit maximal transcriptional activity in CaCo-2 cells, but not in HepG2 cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
266
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
24161-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1660893-Apolipoproteins B, pubmed-meshheading:1660893-Base Sequence, pubmed-meshheading:1660893-Carcinoma, Hepatocellular, pubmed-meshheading:1660893-Cell Line, pubmed-meshheading:1660893-Chloramphenicol O-Acetyltransferase, pubmed-meshheading:1660893-Chromosome Deletion, pubmed-meshheading:1660893-Colonic Neoplasms, pubmed-meshheading:1660893-DNA, Neoplasm, pubmed-meshheading:1660893-Deoxyribonuclease I, pubmed-meshheading:1660893-Enhancer Elements, Genetic, pubmed-meshheading:1660893-Genes, pubmed-meshheading:1660893-Humans, pubmed-meshheading:1660893-Liver Neoplasms, pubmed-meshheading:1660893-Models, Genetic, pubmed-meshheading:1660893-Molecular Sequence Data, pubmed-meshheading:1660893-Plasmids, pubmed-meshheading:1660893-Promoter Regions, Genetic, pubmed-meshheading:1660893-Recombinant Fusion Proteins, pubmed-meshheading:1660893-Regulatory Sequences, Nucleic Acid, pubmed-meshheading:1660893-Restriction Mapping, pubmed-meshheading:1660893-Transfection
pubmed:year
1991
pubmed:articleTitle
The mechanisms by which a human apolipoprotein B gene enhancer and reducer interact with the promoter are different in cultured cells of hepatic and intestinal origin.
pubmed:affiliation
Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140-0608.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.